Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Mitochondria-localized caveolin in adaptation to cellular stress and injury.

Fridolfsson HN, Kawaraguchi Y, Ali SS, Panneerselvam M, Niesman IR, Finley JC, Kellerhals SE, Migita MY, Okada H, Moreno AL, Jennings M, Kidd MW, Bonds JA, Balijepalli RC, Ross RS, Patel PM, Miyanohara A, Chen Q, Lesnefsky EJ, Head BP, Roth DM, Insel PA, Patel HH.

FASEB J. 2012 Nov;26(11):4637-49. doi: 10.1096/fj.12-215798. Epub 2012 Aug 2.

2.

Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection.

See Hoe LE, Schilling JM, Tarbit E, Kiessling CJ, Busija AR, Niesman IR, Du Toit E, Ashton KJ, Roth DM, Headrick JP, Patel HH, Peart JN.

Am J Physiol Heart Circ Physiol. 2014 Sep 15;307(6):H895-903. doi: 10.1152/ajpheart.00081.2014. Epub 2014 Jul 25.

3.

Cardioprotective trafficking of caveolin to mitochondria is Gi-protein dependent.

Wang J, Schilling JM, Niesman IR, Headrick JP, Finley JC, Kwan E, Patel PM, Head BP, Roth DM, Yue Y, Patel HH.

Anesthesiology. 2014 Sep;121(3):538-48. doi: 10.1097/ALN.0000000000000295.

4.

Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning.

Tsutsumi YM, Horikawa YT, Jennings MM, Kidd MW, Niesman IR, Yokoyama U, Head BP, Hagiwara Y, Ishikawa Y, Miyanohara A, Patel PM, Insel PA, Patel HH, Roth DM.

Circulation. 2008 Nov 4;118(19):1979-88. doi: 10.1161/CIRCULATIONAHA.108.788331. Epub 2008 Oct 20.

5.

Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury.

Horikawa YT, Patel HH, Tsutsumi YM, Jennings MM, Kidd MW, Hagiwara Y, Ishikawa Y, Insel PA, Roth DM.

J Mol Cell Cardiol. 2008 Jan;44(1):123-30. Epub 2007 Oct 11.

6.

Effect of ischemia reperfusion injury and epoxyeicosatrienoic acids on caveolin expression in mouse myocardium.

Chaudhary KR, Cho WJ, Yang F, Samokhvalov V, El-Sikhry HE, Daniel EE, Seubert JM.

J Cardiovasc Pharmacol. 2013 Mar;61(3):258-63. doi: 10.1097/FJC.0b013e31827afcee.

PMID:
23403888
7.

Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.

Horikawa YT, Panneerselvam M, Kawaraguchi Y, Tsutsumi YM, Ali SS, Balijepalli RC, Murray F, Head BP, Niesman IR, Rieg T, Vallon V, Insel PA, Patel HH, Roth DM.

J Am Coll Cardiol. 2011 May 31;57(22):2273-83. doi: 10.1016/j.jacc.2010.12.032.

8.

A kinase interacting protein (AKIP1) is a key regulator of cardiac stress.

Sastri M, Haushalter KJ, Panneerselvam M, Chang P, Fridolfsson H, Finley JC, Ng D, Schilling JM, Miyanohara A, Day ME, Hakozaki H, Petrosyan S, Koller A, King CC, Darshi M, Blumenthal DK, Ali SS, Roth DM, Patel HH, Taylor SS.

Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):E387-96. doi: 10.1073/pnas.1221670110. Epub 2013 Jan 14.

9.

Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3.

Tsutsumi YM, Tsutsumi R, Hamaguchi E, Sakai Y, Kasai A, Ishikawa Y, Yokoyama U, Tanaka K.

Cardiovasc Diabetol. 2014 Sep 7;13:132. doi: 10.1186/s12933-014-0132-9.

10.

Caveolin-3 plays a critical role in autophagy after ischemia-reperfusion.

Kassan A, Pham U, Nguyen Q, Reichelt ME, Cho E, Patel PM, Roth DM, Head BP, Patel HH.

Am J Physiol Cell Physiol. 2016 Dec 1;311(6):C854-C865. doi: 10.1152/ajpcell.00147.2016. Epub 2016 Oct 5.

PMID:
27707689
11.

Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.

Capozza F, Williams TM, Schubert W, McClain S, Bouzahzah B, Sotgia F, Lisanti MP.

Am J Pathol. 2003 Jun;162(6):2029-39.

12.

Evolutionary analysis and molecular dissection of caveola biogenesis.

Kirkham M, Nixon SJ, Howes MT, Abi-Rached L, Wakeham DE, Hanzal-Bayer M, Ferguson C, Hill MM, Fernandez-Rojo M, Brown DA, Hancock JF, Brodsky FM, Parton RG.

J Cell Sci. 2008 Jun 15;121(Pt 12):2075-86. doi: 10.1242/jcs.024588. Epub 2008 May 27.

13.

Electrophysiology and metabolism of caveolin-3-overexpressing mice.

Schilling JM, Horikawa YT, Zemljic-Harpf AE, Vincent KP, Tyan L, Yu JK, McCulloch AD, Balijepalli RC, Patel HH, Roth DM.

Basic Res Cardiol. 2016 May;111(3):28. doi: 10.1007/s00395-016-0542-9. Epub 2016 Mar 29.

14.

Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae.

Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou H Jr, Christ GJ, Edelmann W, Lisanti MP.

Mol Cell Biol. 2002 Apr;22(7):2329-44.

15.

Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.

Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, Shirani J, Razani B, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP.

Am J Pathol. 2002 Jun;160(6):2207-17.

16.

Hypoxic preconditioning promotes the translocation of protein kinase C ε binding with caveolin-3 at cell membrane not mitochondrial in rat heart.

Yu H, Yang Z, Pan S, Yang Y, Tian J, Wang L, Sun W.

Cell Cycle. 2015;14(22):3557-65. doi: 10.1080/15384101.2015.1084446.

17.

Caveolin-1 null (-/-) mice show dramatic reductions in life span.

Park DS, Cohen AW, Frank PG, Razani B, Lee H, Williams TM, Chandra M, Shirani J, De Souza AP, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP.

Biochemistry. 2003 Dec 30;42(51):15124-31.

PMID:
14690422
18.

Caveolin-1 and caveolin-3 form heterooligomeric complexes in atrial cardiac myocytes that are required for doxorubicin-induced apoptosis.

Volonte D, McTiernan CF, Drab M, Kasper M, Galbiati F.

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H392-401. Epub 2007 Nov 2.

19.

Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria.

Li WP, Liu P, Pilcher BK, Anderson RG.

J Cell Sci. 2001 Apr;114(Pt 7):1397-408.

20.

Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components.

Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Niesman IR, Farquhar MG, Insel PA.

J Biol Chem. 2006 Sep 8;281(36):26391-9. Epub 2006 Jul 3.

Supplemental Content

Support Center